We have recently demonstrated that 50% of primitive human long-term culture-initiating cells (LTC-IC) are maintained for up t o 8 weeks in stroma-dependent cultures in which progenitor-stroma contact is prevented (stroma noncontact), or when progenitors are cultured in medium conditioned by stromal feeders. This indicates that factors responsible for LTC-IC maintenance are present in soluble form in stromal supernatant (SN). Although the picogram concentrations of cytokines present in stromal SN can induce the differentiation of CD34+/HLA-DR-(DR-1 cells t o clonogenic cells (colony forming cells; CFC), they maintain only 10% of LTC-IC for 5 weeks, suggesting that factors other than these cytokines are required for LTC-IC maintenance. To characterize the factorb) in stromal SN responsible for LTC-IC maintenance, w e purified glycoproteins and proteoglycans (PG) from the SN of the LTC-IC supportive murine marrow stromal fibroblast cell line M2-10B4 by ion exchange high performance liquid chromatography (HPLC). Culture of DR-cells in a combination of M2-1084-derived PG, but not glycoproteins and picogram concentrations of recombinant human interleukin-6 (IL-61, granulocyte colony-stimulating factor (G-CSF), stem cell factor (SCF), leukemia inhibitory factor (LIF), ACTORS THAT ARE required to induce expansion of F human hematopoietic stem cells are still largely unknown. In vivo, hematopoiesis occurs in close contact with the bone marrow (BM) microenvironment. This in vivo marrow microenvironment is mimicked in part by the confluent adherent stromal layer in Dexter-type stromal cultures.' When human hematopoietic progenitors are cultured in contact with stroma (stroma contact culture) in the absence of exogenously added cytokines, 20% of long-term culture-initiating cells (LTC-IC) are maintained for 5 to 8 week^.^.^
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We have recently developed a stroma noncontact culture system in which progenitors are grown separated from stroma in a transwell insert with a 0.4 pm microporous membrane that permits passage of stroma-derived soluble factors, but prevents direct progenitor-stroma ~o n t a c t .~ Culture of CD34+ HLA-DR-cells (DR-cells) in such cultures results not only in the generation of committed progenitors, but also in the maintenance of 50% of LTC-IC for up to 8 weeks. LTC-IC maintenance occurs to the same degree when DRcells are cultured in medium conditioned for 2 to 4 days by human marrow stromal feeders (stromal supernatant; SN) or SN from the murine marrow stroma-derived cell line M2-10B4, but in the absence of a feeder layer present in the same culture vessel."' These studies indicated that factors required for ex vivo LTC-IC maintenance are secreted by freshly prepared human marrow stromal feeders and also by the murine marrow stroma-derived cell line M2-10B4.
A variety of growth promoting and growth inhibitory cytokines are present in SN of human stromal or M2-10B4 feedStroma-free'' cultures supplemented with one or ers. 3,7,8 " more defined growth-promoting with or without growth-inhibiting cytokines induce marked cell expansion and generate large numbers of committed progenitors (colony forming cells [CFC] ).9,'o However, less than 10% of LTC-IC are granulocyte-macrophage colony-stimulating factor (GM-CSF), and macrophage inflammatory protein-la (MIP-la) resulted in the recovery of 96% -t 8% of LTC-IC maintained in cultures supplemented with unfractionated stromal SN. LTC-IC maintenance was largely retained after digestion of the PG-rich fraction with proteinase K and after dissociative gel filtration chromatography, but was completely abolished following treatment with nitrous acid, which digests heparan sulfate glycosaminoglycans (HS GAG). As for M2-10B4-derived HS GAG, high concentrations of bovine kidney HS GAG, but not bovine tracheal chondroitin sulfate, significantly improved cytokine-mediated LTC-IC maintenance.
Maintenance of LTC-IC by these nonmarrow-derived HS GAG was, however, significantly lower than that seen with M2-1084-derived HS. These studies demonstrate a role for marrow stroma-derived HS GAG in the long-term in vitro maintenance of human LTC-IC. Further structure-function analysis of these HS GAG may have important implications for ex vivo stem cell expansion and gene transfer into hematopoietic progenitors. 0 1996 b y The American Society of Hematology.
maintained for 5 to 8 weeks.' Recent studies from our laboratory suggest that decreased LTC-IC maintenance may be due to terminal differentiation of LTC-IC rather than failure to induce their proliferation." We hypothesized therefore, that additional, as yet undefined stromal factors are required for the long-term maintenance of LTC-IC observed in stromal SN cultures. These factors may include novel cytokines and/or extracellular matrix components that can directly or indirectly modulate progenitor growth and differentiati~n.'~." Proteoglycans (PG) are heterogeneous macromolecules consisting of a core protein and multiply sulfated side chains comprised of repeating disaccharide units, referred to as glycosaminoglycans. They are produced by both hematopoietic and stromal cells.'2,'8-22 Although ubiquitous, differences in 3230 GUPTA, MCCARTHY, AND VERFAlLLlE core proteins, the type and number of sugar residues, and the number and location of sulfate groups provide unique characteristics to proteoglycans produced in specific locations. Among the GAG, heparan sulfate (HS) is widely expressed on cell surfaces in the extracellular matrix and is shed by cells in culture into the media." It is thought that the extensive structural diversity of HS is an important determinant of its functional specificity and ability to modulate cell proliferation and differentiation.21 27 A number of studies have demonstrated a role for proteoglycans or GAG in hematopoiesis. Stromal HS and hyaluronate are, in part, responsible for the binding of hematopoietic progenitors to the marrow m i c r~e n v i r o n m e n t .~~~~~ In addition, heparin and HS stimulate megakaryopoiesi~,~~ BM-derived HS induces differentiation of the myeloid cell line HL-60," and addition of P-D-xyloside to long-term bone marrow culture (LTBMC), which uncouples chondroitin sulfate (CS) GAG synthesis from CS proteoglycan synthesis, increases CFC production.'2 GAG and PG may regulate cell growth and differentiation through complex interactions with both growth-promoting and growth-inhibiting cytokines or with cytokine receptors and, therefore, modulate the action of these cytokines on progenitors."~'"*' ")-" They also complex with other extracellular matrix (ECM) molecules such as fibronectin (FN) and thrombospondin (TSP), known to be important for localization of hematopoietic progenitors, as well as regulation of their proliferati~n.'~.'~,~~ These observations led us to evaluate if one of the factors secreted by stroma responsible for LTC-IC maintenance is a PG.
We demonstrate here that heparan sulfate GAG secreted by the murine cell line M2-10B4 in combination with concentrations of cytokines detected in stromal SN support longterm maintenance of human LTC-IC in vitro.
MATERIALS AND METHODS
Cell separation. Lin-/CD34+/HLA-DR-cells (DR-cells) were obtained from the BM of healthy volunteer donors after informed consent and purified by fluorescence activated cell sorting (FACS) as previously de~cribed.~.'~ Human marrow stromal layers were established as described.3s When confluent, the flasks were irradiated with 1,250 rads. Irradiated stromal feeders were maintained at 37°C by weekly replacement of half the medium with fresh LTBMC medium, consisting of Iscove's modified Dulbecco's medium (IMDM) with 12.5% fetal calf serum (FCS) (Hyclone Laboratories, Logan, UT), 12.5% horse serum (Stemcell Technologies Inc, Vancouver, Canada), 2 mmol/L L-glutamine (GIBCO BRL, Gaithersburg, MD), 1,000 U/mL penicillin, 100 U/mL streptomycin and IO-' moliL hydrocortisone. The murine BM stromal cell line M2-10B4 (a kind gift from Dr Connie Eaves, Vancouver, Canada) was cultured in Roswell Park Memorial Institute-1640 (RPMI-1640) medium (GIBCO) supplemented with 10% FCS. When confluent, flasks were irradiated with 2,000 rads, and all the medium replaced by LTBMC medium.
Supernatants from irradiated cultures of human BM stroma or M2-10B4 feeders were harvested 2 to 4 days after a half-medium change, centrifuged at 400g for 10 minutes to remove cell debris and frozen at -70°C until use.
Recombinant human cytokines used in long-term cultures included 500 pg/mL granulocyte-colony stimulating factor (GStromal layers.
Supernatants.

Cytokinrs.
CSF) (Neupogen; Amgen, Thousand Oaks, CA), 50 pg/mL granulocyte macrophage-colony stimulating factor (GM-CSF) (Immunex Corp, Seattle, WA), 200 pg/mL stem cell factor (SCF) (a kind gift from Amgen), 50 pg/mL leukemia inhibitory factor (LIF) (R&D Systems Inc, Minneapolis, MN), 200 pg/mL macrophage inflammatory protein-la (MIP-la) (R&D Systems), and 2 ng/mL interleukin-6 (IL-6) (a kind gift from Dr G. Wong, Genetics Institute, Boston, MA). These concentrations of cytokines are similar to those present in BM stromal SN.'.' LTBMC medium or reconstituted media sufficient for the entire duration of culture (5 weeks) was supplemented with these cytokines at day 0 and frozen in aliquots at -70°C. Every 2 to 3 days an aliquot was thawed and kept at 4°C for use in longterm cultures.
DR.. cells were plated in collagen-coated transwell inserts (0.4 pn microporous filter) (Costar Corp, Cambridge, MA) placed in 24-well culture plates. LTBMC medium, unfractionated stromal SN or reconstituted media (800 pL) were placed in the lower wells. Cultures were incubated in a humidified 5% CO, atmosphere at 37°C for 5 weeks. Culture media were changed five times a week by placing 800 pL of fresh medium in new wells of 24-well plates and transferring the transwell inserts to the new wells. After 5 weeks, cells were recovered from the transwell inserts by vigorous washing. Cells were then either plated in methylcellulose culture to enumerate CFCs or replated in limiting dilution assays (LDA) on secondary M2-10B4 feeders to enumerate LTC-IC as previously de~cribed.~.~ The absolute number of LTC-IC was calculated using Poisson statistics.4
Progeny from long-term cultures were plated in methylcellulose (final concentration I . 12%) supplemented with 30% FCS, 3 IU recombinant erythropoietin (Amgen) and either 5% to 10% SN from the bladder carcinoma cell line 5637 or 5 ng/mL interleukin-3 (IL-3) (a kind gift from Dr G. Wong, Genetics Institute). Cultures were incubated in humidified 5% CO, atmosphere at 37°C and CFC were counted at day 14 of culture.
Supernatants from M2-10B4 feeders were obtained as described above. To radioactively label sulfated glycoproteins and proteoglycans in the SN, 50 pCi/ml Na, "SO4 (ICN Biomedicals Inc, Irvine, CA) in sulfate-replete LTBMC medium was added to one of every 10 flasks for 24 hours before harvesting. The SN were dialyzed in 12,000 to 14,000 molecular weight cut off (MWCO) dialysis tubing (Spectrum Medical Industries, Houston, TX) against 0.5 moliL sodium acetate, 0.1 molL sodium sulfate, The dialyzate was loaded in 500-mL aliquots onto a 100-mL bed volume DEAE-Sephacel (Sigma) anion exchange column and eluted with TUC buffer containing 1.0 mol/L sodium chloride. Fractions of 20 mL each were collected, and fractions containing the "S radioactivity were pooled and dialyzed against 0.1 molL TUC. Further purification was done by high performance liquid chromatography (HPLC) (Beckman, CA) using a 7.5 x 75 mm TSK DEAE 5PW anion exchange column (Biorad, Richmond, CA) eluted with a linear salt gradient of 0.1 mol/L to 0.8 m o m sodium chloride in TUC buffer as described.3'" Peaks eluting between 0.1 and 0.6 mom salt were separated, dialyzed against 0.1 mmolR. PMSF in deionized water and then against deionized water, and lyophilized. All dialysis steps during the purification process were carried out at 4°C. The lyophilized material was reconstituted in fresh LTBMC medium and Long-term conditioned medium type cultures.
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sterile filtered for use in cultures. At the end of the purification procedure, 45% to 55% of the initially incorporated "S radioactivity was recovered. Therefore, the final volume to which the lyophilized material was reconstituted was adjusted, such that the 35S activity after reconstitution was equivalent to that present in the starting SN.
The concentration of GAG in the lyophilized material from the PG-containing peak was assayed using 1,9-dimethylmethylene blue, using rat chondrosarcoma PG as the standard. The size of the purified PG was estimated using a Sepharose CL-6B gel filtration column3' with a bed volume of 50 mL, equilibrated and eluted with 4 m o m guanidine hydrochloride and 0.05 m o m sodium acetate, pH 5.8, at a rate of 4 mL/hr; 1 mL fractions were collected.
"S labeled PGs were subjected to gel filtration on Sephadex G-50 (Sigma) columns equilibrated in 4.36 mL/L formic acid, 8.45 mL/L ammonium hydroxide, and 0.02% sodium azide, pH 6.0, before and after enzymatic digestion of GAG at 37°C for 4 hours with 0.1 UlmL chondroitinase ABC (Seikagaku Corp, Tokyo, Japan) or with nitrous acid, as previously de~cribed.'~.~~ Digestion of M2-IOB4-derived PG core proteins and HS GAG for use in long-term cultures. An aliquot of M2-1OB4-derived PG was dissolved in 1 mL phosphate-buffered saline (PBS) and 1.8 mg proteinase K (Sigma) in 1 mL potassium dihydrogen phosphate (Sigma), pH 7.5 was added. The mixture was incubated at 40°C for 2 hours. Proteinase K was inactivated by the addition of PMSF to 50 ,ug/mL followed by boiling at 100°C for 1 minute. Digested products were dialyzed against water. Digestion of the core proteins of the PG, as well as other residual proteins, was confirmed by agarose-3% polyacrylamide gel electrophoresis."" For the digestion of HS by nitrous acid, M2-1OB4-derived PG were dissolved in 0.5 mL water, and 2.5 mL each of 1 N HC1 and N-butyl nitrite were added and the mixture agitated at room temperature for 2 hours. The reaction was stopped by neutralization with I N NaOH, and the products dialyzed against water in 12,000 to 14,000 MWCO tubing and lyophilized. Digestion of HS was confirmed by Sephadex 13-50 gel filtration chromatography.
Composite agarose polyacrylamide gel electrophoresis. M2-10B4 PG before and following digestion with proteinase K were resolved by electrophoresis on composite agarose-3% acrylamide gels prepared as de~cribed.~' GAG were visualized by staining with 0.2% Toluidine blue and gels photographed after destaining with 3% acetic acid and water. Transwells removed from wells containing stromal feeder layers were washed extensively and bound PG eluted from the membranes by incubation in 2.5% trypsin (Sigma) in PBS at 37°C for 20 to 30 minutes. The eluate was subjected to DEAE Sephacel ion exchange HPLC. Fractions containing 35S labeled PG were pooled, dialyzed, and lyophilized. The size distribution of these PG was estimated by Sepharose CL-6B gel filtration chromatography.
Elution of cytokines from transwells. Fresh transwell inserts were placed in 24-well plates containing irradiated human marrow stromal layers. No hematopoietic progenitors were plated in these experiments. After 1 week, transwell inserts were removed from the wells, washed extensively in cold PBS, and the membranes cut out. To prepare eluates, membranes were suspended in 2 mL of 3 mow L NaCl for 30 minutes at 4°C. following which the membranes were discarded and the eluates dialyzed three times against PBS at 4°C. Cytokine concentrations in unmanipulated stromal SN, following HPLC purification and in the eluates from transwell membranes were measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits for human IL-6, G-CSF, SCF, LIF, and MIP-la (all kits from R&D Systems) as per the manufacturer's recommendations.
Results of data are reported as the mean ? 1 standard
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error of the mean. Levels of significance were determined by twosided Student's r-test.
RESULTS
Cytokines present in stromal SN do not support LTC-IC maintenance. Approximately 50% of LTC-IC are maintained for 5 to 8 weeks when DR-cells are cultured in SN from marrow stroma or M2-10B4, but without exogenously added c y t~k i n e s~.~ (and unpublished observations). However, less than 10% of LTC-IC are maintained when cultured in the presence of defined cytokines, but in the absence of stroma? Because the concentrations of cytokines in stromal SN3.7.8 are 10-fold to 1,000-fold lower than those regularly used in stroma-free cytokine supplemented c~l t u r e ,~~~~~~'~ we examined first if LTC-IC maintenance seen in stromal SN cultures can be attributed to these "physiologic" picogram rather than nanogram amounts of cytokines. Fresh unconditioned LTBMC medium was supplemented with a combination of cytokines (IL-6, G-CSF, SCF, LIF, MIP-la, and GM-CSF) at concentrations found in stromal SN. were recovered from cytokine only cultures ( P < .001; Fig   1) . This suggests that besides these cytokines, additional factors are required for LTC-IC maintenance.
Partial purification and characterization of PG from M2-10B4 SN. To determine the nature of factor(s) responsible for this effect, we partially purified proteoglycans and glycoproteins from SN of M2-10B4 cells by DEAE Sephacel anion exchange HPLC. As has been shown for fresh marrow stromal SN,'8,ZZ M2-10B4 SN contained two peaks of ?5 radioactivity (Fig 2A) . The major PG containing peak (peak B) eluted at 0.40 to 0.45 m o m NaCl and contained only small amounts of proteins. The PGs present in peak B eluted from a Sepharose CL-6B column at a K,, of 0.48 (Fig 2B) . Sequential digestion of the PGs with chondroitinase ABC and nitrous acid followed by Sephadex (3-50 chromatography confirmed that 88% to 90% of the GAG in M210-B4 peak B were CS/DS, as they were sensitive to enzymatic digestion by chondroitinase ABC, and the remainder (10% to 12%) were HS, as they were sensitive to digestion with nitrous acid. This indicates that the proteoglycans in the SN were largely chondroitin sulfate and/or dermatan sulfate with a smaller proportion of HS PGs. A smaller peak of radioactivity (peak A) eluted at 0.15 m o w NaCl and contained the bulk of proteins present in the stromal SN.
To examine further if cytokines were present in peak B, we performed ELISA assays for IL-6 and MIP-la. Neither of these cytokines, although present in unfractionated SN, could be detected following HPLC purification. As shown below, heparin binding cytokines such as MIP-la, however, are associated with PG, but likely degraded during the purification process. Indeed, when MIP-la was dissolved in 1 m o w TUC buffer containing 50 to 250 pg/mL heparansulfate dualbumin (HSOVA), followed immediately by dialysis against water and lyophilization, 20% of MIP-la detect- able by ELlSA was lost. The loss of MIP-la increased with prolonged treatment with 1 mol/L TUC (as would occur in the process of purification of peak B from M210-B4 supematant), and only 65% of MIP-la was detectable when MIPla + HSOVA in 1 m o l n TUC was incubated for 72 hours at 4°C before dialysis and lyophilization. That the presence of HS itself did not render MIP-la undetectable in the ELlSA assay used was demonstrated in experiments in which MIP-la was measured following dissolution in PBS containing HSOVA, but now without dialysis or lyophilization.
We then examined if GAG and PG secreted by stromal feeders could be recovered from the medium present in the transwell insert. As shown in Fig 3, G A G P G found in SN above the stromal feeder could also be recovered from the transwell membrane and medium in the upper chamber of stroma noncontact cultures. Furthermore, PG/GAG in the upper chamber had similar hydrodynamic characteristics (Fig 3) and a similar overall size distribution pattern (not shown) as those present in the lower chamber of these cultures. This demonstrates that stroma-derived soluble PG can diffuse through the microporous transwell membrane. Interestingly, the concentration of MIP-la in the 3 mol/L NaCl eluate from the transwell membrane was 75 pg/mL, suggesting that PG present on the transwell membrane sequestered this heparin-binding cytokine. However, no G-CSF, SCF, LIF, and IL-6, cytokines, which do not bind to heparin, were detected in the eluate.
M2-lOB4-derived, HPLC purified proteoglycans combined with cytokines support LTC-IC maintenance. M2-1 OB4-derived proteoglycans (peak B) and glycoproteins (peak A) were then evaluated for their ability to support maintenance and differentiation of LTC-IC (Fig 4) . HPLC purified M2-1OB4-derived peak A and peak B were reconstituted in LTBMC medium supplemented with or without picogram concentrations of the cytokines G-CSF, GM-CSF, IL-6, LIF, SCF, and MIP-la. The final concentration of GAG in medium containing peak B from M2-10B4 cells was 4.25 pg/mL. Of this, only 10% (0.425 pg/mL) was HS. No LTC-IC were maintained in unconditioned LTBMC medium supplemented with the PG-rich peak B from M2-10B4 without cytokines. The combination of peaks A and B also did not support LTC-IC maintenance in the absence of exogenously added cytokines (not shown). However, the combination of M2-10B4-derived PGs (peak B) and cytokines maintained LTC-IC to the same extent as unfractionated stromal SN (96% 2 8% of stromal SN). In contrast, M2-1 OB4-derived peak A, containing the bulk of proteins and glycoproteins, did not significantly improve cytokineinduced LTC-IC maintenance. A combination of both peaks A and B from M2-10B4 and cytokines did not further improve LTC-IC maintenance observed in cultures supplemented with M2-1OB4-derived peak B and cytokines (not shown). These studies suggest that stroma derived GAG/PG are required for the LTC-IC maintaining capacity of stromal SN.
We also examined the effect of peak A and peak B on the generation of CFC at week 5. Culture of DR-cells in M2-10B4 peak B without cytokines yielded no CFC at week 5. Addition of either of the HPLC purified components did not increase CFC generation over that observed with cytokines alone (cytokines alone: 102% 2 19%; M2-10B4 peak A and cytokines: 118% 2 30%; M2-10B4 peak B and cytokines: 115% 2 28% compared with stromal SN cultures).
Heparan sulfate GAG are responsible for the LTC-IC maintaining capacify of M2-IOB4 PGs. To further demonstrate that PG/GAG play a role in maintaining LTC-IC, we performed three sets of experiments. Because the unmanipulated peak B had no activity without the addition of cytokines, LTC-IC assays were not performed following each of the described treatments in the absence of cytokines. As the activity of stromal SN is equivalent to that of untreated peak B + cytokines (Fig 4) and because peak B material was available in limited quantities, stromal SN was used as the control for these experiments. First, we subjected M2-10B4 peak B to CL-6B dissociative gel filtration column chromatography using 4 mol/L guanidine HCI to remove PG-associated molecules including cytokines. Culture in the 35S labeled fractions obtained after CL-6B gel filtration in combination with cytokines resulted in recovery of the majority of LTC-IC maintained in unfractionated stromal SN cultures (Fig 5) . In a second set of experiments, we digested the HS GAG in peak B with nitrous acid. This resulted in the complete loss of LTC-IC maintaining capability of this peak. Finally, peak B was digested with proteinase K. The proteinase K digested peak B combined with cytokines maintained 83% 2 9% (n = 2) of day 0 LTC-IC for 5 weeks, which is at least equivalent to unfractionated stromal SN cultures. These studies indicate that GAG side chains rather than PG-associated proteins or PG core proteins are responsible for the observed LTC-IC maintenance. As the LTC-IC maintaining capability of M2-10B4 PG was completely abolished following nitrous acid digestion of HS GAG side chains, HS GAG, but not CS/ DS GAG, seem to be responsible for LTC-IC maintenance.
Nonmarrow-derived HS GAG can in part support LTC-IC maintenance. To confirm these observations, we examined if purified, nonmarrow-derived GAG can support in vitro maintenance of LTC-IC (Fig 6) . Bovine kidney HS (5 pg/mL) and cytokines maintained 74% 5 7% of LTC-IC, which was 3.5-fold higher than with cytokines alone (P < .005). When bovine tracheal CS (5 pg/mL) was added to cytokines, only 30% 2 11% of LTC-IC were maintained, which was not better than in the presence of cytokines alone, and significantly lower than in the presence of bovine kidney HS and cytokines ( P < .OS). Likewise, LTC-IC maintenance in the presence of porcine mucosal heparin ( 5 yg/mL) and cytokines was lower than that observed with HS. The combined addition of HS and CS GAG did not improve LTC-IC maintenance seen with HS GAG alone, indicating that the majority of the effect of stromal or M2-10B4 SN on LTC-IC maintenance is likely attributable to specific HS GAG. As for M2-1OB4-derived peak B, bovine kidney HS did not improve cytokine mediated CFC generation at week S (not shown).
DISCUSSION
This study confirms and extends earlier studies from our group demonstrating that factors required for maintenance of LTC-IC are secreted by stromal cell^.^-^." Here we demonstrate that LTC-IC maintenance seen in stroma noncontact and stroma-conditioned medium cultures cannot be attributed to the picogram concentrations of cytokines present in LTBMC. Although these cytokines can induce the differentiation of DR-cells into CFC to the same extent as unfractionated stromal SN, five times less LTC-IC are maintained at 5 weeks compared with stromal SN. The addition of HS GAG secreted by the murine marrow stroma derived cell line M2-10B4 to these picogram concentrations of cytokines resulted in maintenance of LTC-IC to the same extent as unfractionated stromal SN. We have recently demonstrated that maintenance of LTC-IC at S weeks is the result of proliferation of a small fraction of LTC-IC." These studies also demonstrated that failure to maintain LTC-IC for 5 GUPTA, McCARTHY, AND VERFAlLLlE weeks in cytokine-supplemented stroma-free culture is due to the loss of almost all the LTC-IC, likely due to terminal differentiation. The present studies suggest that stroma-derived GAG are at least one of the factors in stromal SN that may prevent terminal differentiation of a fraction of LTC-IC.
Interestingly, although bovine kidney HS GAG support LTC-IC maintenance, addition of a IO-fold higher concentration of these nonmarrow-derived HS GAG resulted in the maintenance of only 60% to 70% of LTC-IC seen with M2-10B4-derived GAG. This suggests that HS GAG capable of maintaining LTC-IC may be ubiquitous, but present at significantly higher concentrations in the marrow microenvironment than in other tissues. We considered the possibility that the effect seen with the PG-rich peak B from M2-10B4 is due to contaminating cytokines. However, peak B from M2-10B4 alone did not induce cell proliferation, generation of CFCs, or LTC-IC maintenance without addition of cytokines. Further, heparin-binding cytokines, such as MIP-la, were progressively lost during the purification treatments, such that MIP-la was no longer detectable in the purified peak B. Following proteinase K digestion or an additional dissociative gel filtration step, M2-10B4 GAG continued to support LTC-IC maintenance. It is, however, still possible that partial loss of activity following dissociative gel filtration is related to removal of unmeasured or unknown cytokines associated with the PG. However, aggregation of the PG following repeated manipulation and CL-6B filtration steps may at least in part account for this loss of activity. In addition, bovine kidney HS, which is devoid of hematopoi- For personal use only. on November 11, 2017. by guest www.bloodjournal.org From etic cytokines, supported 60% to 70% of LTC-IC maintained by stromal SN. Finally, nitrous acid treatment, which digests HS but not CS GAG, entirely abolished the LTC-IC supportive effect of M2-10B4 PG, and LTC-IC were not maintained when cultured in the presence of the recently described chondroitin sulfate isoform of M-CSF combined with cytokines (unpublished observations). These studies indicate that it is unlikely that the LTC-IC maintenance seen with peak B is due to the CS form of M-CSP' or other cytokines associated with the stromal PG, but that marrow stroma-specific HS GAG themselves are modulating the effect of cytokines, resulting in long-term maintenance of LTC-IC in vitro.
The mechanisms underlying the modulatory effects of stromal HS GAG on cytokine dependent LTC-IC maintenance are as yet not known. GAG can regulate cell growth and differentiation indirectly through complex interactions with cytokines and their receptors13.19.27.30-33 or by modulating progenitor-ECM interactions and/or ECM a s~e m b l y . '~. '~.~~.~~ These interactions are at least, in part, related to the charge density of the GAG.25.27 However, even though heparin is more negatively charged than HS, fewer LTC-IC were maintained in the presence of heparin than in the presence of HS. Therefore, the LTC-IC maintaining capability of GAG can not be attributed solely to negative charge density, but may at least, in part, be due to structural specificity.
Glycosaminoglycans bind and concentrate cytokines such as GM-CSF, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-P, and MIP-la. '9,30,3',33 We demonstrate that stroma-derived PG and GAG deposited on the transwell membrane can sequester heparin binding cytokines such as MIP-la. In addition, HS GAG can bind ECM components such as fibronectin and TSP,15*34 components known to serve as competence factors for cytokine-mediated proliferation of hematopoietic progenitors. l4 Stromal HS GAG, which can also mediate hematopoietic progenitor adh e s i~n , '~,~~ may thus serve to colocalize progenitors with heparin-binding cytokines and ECM components in "stem cell niches" that regulate conservation, proliferation, and differentiation of primitive progenitor^.'^.^^ Other possible mechanisms of action may be that HS GAG directly modulate cytokine-mediated LTC-IC maintenance by presenting cytokines in a biologically more active or qualitatively different form to
As has been shown for other biological systems, HS GAG may also have direct growth promoting or inhibitory effects on LTC-IC by binding to transcription factors, modulating c-fos, c-myc, and DNA polymerase or blocking cell cycle progression at the GdG, pha~e.'~,'~
In conclusion, we demonstrate here that HS GAG secreted by marrow stromal cells combined with the picogram concentrations of cytokines found in LTBMC can maintain at least 50% of LTC-IC for up to 5 weeks in vitro, which is five-fold higher than the LTC-IC maintenance observed in the presence of these cytokines alone. These studies indicate that aside from known cytokines, stromal ECM components such as HS GAG may be required to successfully induce long-term in vitro maintenance and/or expansion of human hematopoietic stem cells. Further molecular characterization of such HS GAG may, therefore, have important consequences for ex vivo stem cell culture and retroviral gene transduction protocols.
